“…While some of these conditions may be considered "rare" to public health experts, effective treatment can result in substantial reductions of mortality and lifelong morbidity. Obtaining more accurate estimates of mortality is also important to measure disparities with higher-income countries, and may help estimate the resources needed to narrow the global gap in outcomes, as has been done for trauma and certain congenital conditions [23,24]. Finally, for non-fatal conditions, using contextually relevant, reliable tools to measure morbidity will likely be more important than mortality.…”